Posts in Bayh-Dole


Winning the Drug Development Debate

We create two new companies around academic inventions every day of the year. The critical role such companies play in drug development is clear. The successful integration …
By Joseph Allen
1 year ago 0

Property Rights Key to Bayh-Dole Act’s Success

The focus of the political advocates pushing march-in may be lower drug costs. But the long-term costs of ripping apart IP rights are far higher and more …
By James Edwards
1 year ago 5

NIH Director Collins Stands Up to the March in Mob

The problem with this theory is that the Bayh-Dole Act does not provide agencies the authority to regulate product prices. The law allows universities and contractors to …
By Joseph Allen
2 years ago 0

UN Access to Medicines Panel Undermines Bayh-Dole 

We cannot know what biological killer will next emerge, when it will be born and where globalization’s winds will take it. But we do know that …
By Chris Gallagher
2 years ago 1

When Government Tried March In Rights To Control Health Care Costs

As we await the decision from the National Institutes of Health (NIH) on the petition backed by Senator Bernie Sanders and others urging that the march in …
By Joseph Allen
2 years ago 10

NIH Pressured to Misuse Bayh-Dole to Control Drug Prices

Secretary Burwell and Director Collins are facing formidable pressure to reinterpret the Bayh-Dole Act for the compulsory licensing of costly drugs arising from federally supported research. And …
By Joseph Allen
2 years ago 6

Winning the Patent Policy Wars

We're in the business of transforming early stage, publicly funded research into useful products. The odds against success are long as commercialization requires years of hard work, …
By Joseph Allen
2 years ago 2

Senate Small Business Committee hearing focuses protecting rights of patent owners

Committee chairman Senator David Vitter (R-LA) began the hearing by speaking about the importance of a strong patent system to small businesses all over America, as well …
By Steve Brachmann
2 years ago 5

Tech Transfer 101: It’s A Better World with University Technology

AUTM collects quantitative data and facts about the benefits of university tech transfer, but the qualitative evidence is actually the most important. With the Better World Report, …
By Gene Quinn
2 years ago 1

Exit Interview: A Conversation with Outgoing AUTM President Fred Reinhart

During Reinhart's year as President much changed at AUTM. There was a concerted effort to transition to a a strategic board of directors that would result in …
By Gene Quinn
2 years ago 1

Bayh-Dole Under March-in Assault: Can It Hold Out?

The new year was hardly underway before Representative Lloyd Doggett (D-TX) and 50 of his House colleagues sent a letter to Health and Human Services Secretary Sylvia Burwell …
By Joseph Allen
2 years ago 0

Bayh-Dole at 35: Lauded in Kazakhstan, Dissed in Boston

Being abroad where Bayh-Dole is recognized as the gold standard in technology transfer made the article more jarring. Like whack a mole, the refuted claims of the …
By Joseph Allen
2 years ago 4

Why you shouldn’t trust Fortune Magazine on patent policy

Like a lemming running off a cliff, Fortune author Jeff John Roberts ignores easily verifiable historical truths in what can really only be described as a hit …
By Gene Quinn & Steve Brachmann
2 years ago 3

Patent policy is too important for subterfuge and academic folly

As the new academic year starts in earnest we can be sure that the all too familiar attacks on the patent system will reemerge, as they always …
By Gene Quinn
2 years ago 3

Looking Down on the Patent System from the Ivory Tower

The patent system is not a tool for entrenched interests to stifle competition, as so many professors seem to believe. Patents allow independent inventors and small companies …
By Joseph Allen
2 years ago 26